What happened
BCWorld Pharm reported consolidated results for FY2025: revenue of US$52.3M (+1.3% year on year), operating profit of US$1.57M (+51.9% year on year) and a net loss of US$1.96M.
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$52.3M |
|---|---|
| Revenue vs a year earlier | +1.3% |
| Operating profit | US$1.57M |
| Net income | −US$1.96M |
| Period | FY2025 (consolidated) |
| Filed | 2026-02-02, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260202900352 → open original filing |
Source: DART. Information only, not investment advice.